Cargando…
Translating Molecules into Imaging—The Development of New PET Tracers for Patients with Melanoma
Melanoma is a deadly disease that often exhibits relentless progression and can have both early and late metastases. Recent advances in immunotherapy and targeted therapy have dramatically increased patient survival for patients with melanoma. Similar advances in molecular targeted PET imaging can i...
Autores principales: | Vercellino, Laetitia, de Jong, Dorine, Dercle, Laurent, Hosten, Benoit, Braumuller, Brian, Das, Jeeban Paul, Deng, Aileen, Moya-Plana, Antoine, A’Keen, Camry, Yeh, Randy, Merlet, Pascal, Baroudjian, Barouyr, Salvatore, Mary M., Capaccione, Kathleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139963/ https://www.ncbi.nlm.nih.gov/pubmed/35626272 http://dx.doi.org/10.3390/diagnostics12051116 |
Ejemplares similares
-
Yield of FDG PET/CT for Defining the Extent of Disease in Patients with Kaposi Sarcoma
por: Pesqué, Louise, et al.
Publicado: (2022) -
18FDG PET Assessment of Therapeutic Response in Patients with Advanced or Metastatic Melanoma Treated with First-Line Immune Checkpoint Inhibitors
por: Rivas, Alexia, et al.
Publicado: (2022) -
Advances in PET/CT Imaging for Breast Cancer
por: de Jong, Dorine, et al.
Publicado: (2023) -
Novel Targets, Novel Treatments: The Changing Landscape of Non-Small Cell Lung Cancer
por: de Jong, Dorine, et al.
Publicado: (2023) -
More than Just Skin-Deep: A Review of Imaging’s Role in Guiding CAR T-Cell Therapy for Advanced Melanoma
por: Prendergast, Conor M., et al.
Publicado: (2023)